This paradigm has led to growing advocacy for earlier screening and intervention, particularly in populations with genetic predispositions (e.g., MTHFR polymorphisms), renal dysfunction, or low dietary folate intake). This evidence concerns the gene MTHFR and Abnormal renal physiology.